Yes, Bactrim is one of the most commonly prescribed antibiotics for urinary tract infections. It’s a combination of two active ingredients (trimethoprim and sulfamethoxazole) that work together to kill the bacteria causing the infection. For a straightforward, uncomplicated UTI, a three-day course is the standard treatment, and it clears the infection in roughly 79 to 90 percent of cases depending on whether the bacteria are susceptible to the drug.
How Bactrim Treats a UTI
Bactrim targets the bacteria responsible for most UTIs, particularly E. coli, by blocking two steps in the process bacteria use to make folic acid. Without folic acid, the bacteria can’t reproduce and die off. The standard dose for an uncomplicated UTI is one double-strength tablet (160/800 mg) taken twice daily for three days. In some situations, such as more complicated infections or in older adults, your provider may prescribe a longer course of seven to ten days.
Clinical trials show the drug works well when bacteria are susceptible to it. In one head-to-head trial comparing Bactrim to nitrofurantoin (Macrobid), both antibiotics produced a 90 percent early clinical cure rate, and after 30 days the numbers were still comparable: 79 percent for Bactrim versus 84 percent for nitrofurantoin, a difference that was not statistically significant. However, a subgroup analysis from the same trial revealed a critical detail: when the UTI-causing bacteria were resistant to Bactrim, the cure rate dropped to just 41 percent.
When Bactrim May Not Be the Best Choice
Antibiotic resistance is the biggest factor that determines whether Bactrim will work for your UTI. Guidelines recommend Bactrim as a first-line option only in areas where fewer than 20 percent of local E. coli samples are resistant to it. In many parts of the United States and other countries, resistance rates have climbed above that threshold, which is why some providers now prefer nitrofurantoin or fosfomycin as a starting point instead.
If your provider orders a urine culture before or alongside your prescription, the lab results will confirm whether the specific bacteria causing your infection respond to Bactrim. When the bacteria are susceptible, the drug works reliably. When they’re not, you’ll likely need a switch to a different antibiotic.
Bactrim Compared to Other UTI Antibiotics
Bactrim, nitrofurantoin, and fluoroquinolones (like ciprofloxacin) all treat uncomplicated UTIs effectively. In clinical trials, a three-day course of Bactrim produced eradication rates comparable to three-day courses of ciprofloxacin and ofloxacin immediately after treatment. At follow-up four to six weeks later, ciprofloxacin showed slightly better bacteriologic clearance, but the practical difference for most patients with uncomplicated infections is small.
One advantage Bactrim has over nitrofurantoin is the shorter treatment course: three days versus five. The trade-off is that resistance to Bactrim is more common. Nitrofurantoin has maintained lower resistance rates over the decades because it works through multiple mechanisms that are harder for bacteria to evade. For complicated UTIs, Bactrim is considered less well-studied than some alternatives, though it may still be appropriate in certain situations based on culture results.
Side Effects and Sulfa Allergy
Bactrim is a sulfa drug, and roughly 3 to 6 percent of people have some degree of sulfa allergy. If you’ve ever been told you’re allergic to sulfa medications, Bactrim is off the table. Common allergic symptoms include skin rash, hives, itching, and increased sun sensitivity. More serious reactions, though uncommon, can involve swelling of the mouth or tongue, difficulty breathing, or skin blistering. A rare but severe complication called Stevens-Johnson syndrome causes painful blistering of the skin and mucous membranes and requires emergency care.
Even without an allergy, Bactrim can cause nausea, vomiting, diarrhea, or headache in some people. These tend to be mild and resolve once the course is finished. Staying well-hydrated during treatment helps both the side effects and the UTI itself.
Pregnancy Considerations
Bactrim’s safety during pregnancy depends heavily on timing. During the first trimester, trimethoprim can lower folic acid levels in the body, and some studies have linked first-trimester use to a slightly increased chance of heart defects, neural tube defects, and cleft lip or palate. Two studies also reported a higher rate of miscarriage. If Bactrim is the only reasonable option in early pregnancy, providers typically recommend taking extra folic acid alongside it.
The second and third trimesters are a different story. The American College of Obstetricians and Gynecologists considers Bactrim a first-line UTI treatment during this period. Some research does suggest a possible association with preterm delivery or lower birth weight, so your provider will weigh the risks of the infection against the risks of the medication.
Kidney Function and Dosing
If you have reduced kidney function, Bactrim requires extra caution. The standard double-strength tablet should be avoided unless kidney filtration capacity (creatinine clearance) is above 50 mL per minute. Below that level, a single-strength tablet is safer because the kidneys clear the drug more slowly, allowing it to build up to potentially harmful levels. Your provider can check kidney function with a simple blood test before prescribing.
For otherwise healthy adults with normal kidney function, Bactrim remains one of the most straightforward and affordable UTI treatments available, typically costing just a few dollars even without insurance. Its effectiveness, short treatment course, and decades of use make it a reliable option when local resistance patterns support it.